Dow Jones

38 852,86

-0,55%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Curagen Corp. (MM) (CRGN)
Curagen Corp. (MM) (CRGN) Actualités

CRGN

Curagen Corp. (MM) (CRGN)

Curagen Corp. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:CRGN

1 2 3 4 5 6 7 8 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
02/10/2009	12h02	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
01/10/2009	22h28	Edgar (US Regulatory)	(25-NSE)	NASDAQ:CRGN	Curagen Corp. (MM)
01/10/2009	20h29	Business Wire	Celldex Therapeutics Announces Completed Acquisition of CuraGen Corporation	NASDAQ:CRGN	Curagen Corp. (MM)
01/10/2009	00h00	Business Wire	Celldex and CuraGen Stockholders Approve Acquisition of CuraGen Corporation	NASDAQ:CRGN	Curagen Corp. (MM)
25/09/2009	22h33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRGN	Curagen Corp. (MM)
03/09/2009	12h01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
28/08/2009	23h27	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)	NASDAQ:CRGN	Curagen Corp. (MM)
17/08/2009	22h50	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:CRGN	Curagen Corp. (MM)
05/08/2009	20h03	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:CRGN	Curagen Corp. (MM)
31/07/2009	12h00	PR Newswire (US)	CuraGen Reports Second Quarter 2009 Financial Results	NASDAQ:CRGN
22/06/2009	23h07	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:CRGN	Curagen Corp. (MM)
19/06/2009	19h45	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	NASDAQ:CRGN	Curagen Corp. (MM)
17/06/2009	12h30	PR Newswire (US)	CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer	NASDAQ:CRGN	Curagen Corp. (MM)
10/06/2009	23h02	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:CRGN	Curagen Corp. (MM)
09/06/2009	21h22	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:CRGN	Curagen Corp. (MM)
03/06/2009	21h42	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NASDAQ:CRGN	Curagen Corp. (MM)
02/06/2009	12h30	PR Newswire (US)	CuraGen Updates CR011-vcMMAE Data at ASCO	NASDAQ:CRGN	Curagen Corp. (MM)
29/05/2009	22h50	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:CRGN	Curagen Corp. (MM)
29/05/2009	12h54	Business Wire	Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation	NASDAQ:CRGN	Curagen Corp. (MM)
28/05/2009	12h30	PR Newswire (US)	CuraGen to Present CR011-vcMMAE Data at ASCO	NASDAQ:CRGN	Curagen Corp. (MM)
19/05/2009	21h15	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:CRGN	Curagen Corp. (MM)
23/04/2009	17h03	PR Newswire (US)	/C O R R E C T I O N -- CuraGen Corporation/	NASDAQ:CRGN	Curagen Corp. (MM)
23/04/2009	12h30	PR Newswire (US)	CuraGen Reports First Quarter 2009 Financial Results	NASDAQ:CRGN	Curagen Corp. (MM)
10/03/2009	22h06	Edgar (US Regulatory)	Annual Report (10-K)	NASDAQ:CRGN	Curagen Corp. (MM)
27/02/2009	12h30	PR Newswire (US)	CuraGen Announces Board of Director Changes	NASDAQ:CRGN	Curagen Corp. (MM)
18/02/2009	12h30	PR Newswire (US)	CuraGen's Board of Directors to Evaluate Strategic Initiatives	NASDAQ:CRGN	Curagen Corp. (MM)
29/01/2009	12h30	PR Newswire (US)	CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009	NASDAQ:CRGN	Curagen Corp. (MM)
15/01/2009	19h33	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	NASDAQ:CRGN	Curagen Corp. (MM)
05/11/2008	12h30	PR Newswire (US)	CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference	NASDAQ:CRGN	Curagen Corp. (MM)
03/11/2008	12h45	PR Newswire (US)	CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metast	NASDAQ:CRGN	Curagen Corp. (MM)